Latest filing published 15 May 2026 for Lyra Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by W. Bradford Smith span 2 companies, the busiest being Q32 Bio Inc. and Lyra Therapeutics, Inc. Between 1 January 2022 and 14 May 2026, the trades on record add up to 4 filings.
On the market, this insider has only sold: 1 sale, €4,868 in total. The rest of the record consists of 2 option exercises.
On 15 May 2026 came the latest disclosure, a transaction in Lyra Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations